เริ่มกันเลย
ABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COM

ABBVIE INC CEDEAR EACH 10 REPR 1 COM

ไม่มีการซื้อขาย
ดูในซูเปอร์ชาร์ต
ภาพรวม การเงิน ข่าว การสนทนา เทคนิค ฤดูกาล
พันธบัตร

หุ้นกู้ ABBV

ด้านล่างคือรายการของหุ้นกู้ ABBVIE INC CEDEAR EACH 10 REPR 1 COM นักลงทุนมักเลือกใช้หุ้นกู้ของบริษัทเพื่อเพิ่มเสถียรภาพในช่วงเวลาที่ตลาดผันผวน ศึกษาราคา อัตราผลตอบแทน และสถิติอื่นๆ และค้นหาการลงทุนที่เชื่อถือได้
สัญลักษณ์
YTM %
ปริมาณการซื้อขาย
ราคา %
ดอกเบี้ย %
วันครบกำหนดอายุ
ยอดคงค้าง
มูลค่าหน้าตั๋ว
จำนวนเงินขั้นต่ำ
ผู้ออก
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
8.14%50 K74.10%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7.69%15 K77.85%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7.40%4 K78.73%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AA5QDALLERGAN FNDG 15/25
7.34%099.72%3.80%2025-03-15130.22 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
7.11%20 K84.96%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.96%10.89 M82.92%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5.82%086.97%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.77%6.89 M90.54%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.75%449 K91.23%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.74%26 K90.47%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.74%3.78 M88.24%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5.74%090.29%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.70%5.5 M97.54%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.69%13.7 M86.82%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.68%5.45 M92.35%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.67%1.07 M90.76%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.60%719 K97.79%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
5.47%1.8 M99.87%3.80%2025-03-152.89 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.46%642 K99.00%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5.37%092.47%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5.26%094.92%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5.26%1.18 M95.32%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5.09%42.77 M99.77%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.90%4.32 M93.44%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.83%5.37 M100.58%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4.80%099.71%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.75%5.15 M100.19%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4.57%3.1 M98.97%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4.52%6.45 M97.43%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.52%098.45%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4.49%13.3 M100.60%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
4.26%094.71%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3.95%093.31%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3.86%096.53%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGABBVIE 19/31
3.09%089.70%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3.01%0102.15%3.80%2025-03-151.27 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2.90%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2.88%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591491ABBVIE 20/29
2.85%097.24%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.83%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2.81%097.66%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2.78%099.47%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2.68%095.04%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.35%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.